Bellicum Pharmaceuticals

Tethys Bioscience

Tethys is a cardiometabolic diagnostics company that creates and commercializes breakthrough biomarker-based blood tests that predict imminent disease risk and enable targeted intervention to preempt the onset of chronic conditions such as type 2 diabetes.

Select Venture Capital & Financial Partners

Aeris Capital Intel Capital Kleiner Perkins Caufield & Byers Mohr, Davidow Ventures Wasatch Venture Fund